Health Grants for Researchers

National Institutes of Health · Up to $500K

This NIH/National Cancer Institute R01 funds investigator-initiated early-phase (Phase 0, I, II) clinical trials for cancer diagnosis and treatment; a clinical trial is required. Eligible applicants include universities, research institutions, hospitals, tribal and community organizations, and foreign organizations. The maximum award is just under $500,000. It is geared toward established clinical research teams.

National Institutes of Health · Amount varies

This NIH R01 funds preclinical and patient-based research into how incretin mimetics (such as GLP-1 agents) affect cancer risk. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations; a clinical trial is optional. It requires established research capacity in this area. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R21 funds preclinical and patient-based research into how incretin mimetics (such as GLP-1 agents) affect cancer risk; no clinical trial is allowed. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations. It requires research capacity in this area. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R34 funds early-stage research and pilot studies testing interventions to improve health outcomes in Native American communities, including etiologic research and culturally-informed treatment studies. Eligible applicants include universities, tribal colleges, minority-serving institutions, and community organizations, with some restrictions on foreign entities. No award amount is specified; a clinical trial component is optional.

National Institutes of Health · Amount varies

This NIH R01 supports research on improving access to and quality of evidence-based practices for youth mental health, including in rural, urban, and under-resourced settings. Eligible applicants include universities, research institutions, and tribal and community organizations, but foreign (non-U.S.) organizations are not eligible to apply and foreign components are not allowed. A clinical trial is optional. It is aimed at research teams with mental-health services research expertise. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R01 funds research testing interventions that expand cancer screening and preventive-service uptake in populations facing health disparities, ideally involving community partners. Eligible applicants include universities, minority- and tribal-serving institutions, and community-based organizations, but non-U.S. organizations and their foreign components are excluded. No award amount is specified; this is a research grant requiring a clinical trial component.

National Institutes of Health · Up to $500K

This NIH/National Cancer Institute R01 funds academic-industrial partnerships to translate and validate in vivo imaging, data science, or spectroscopic technologies into tools for cancer and other diseases; a clinical trial is optional. Eligible applicants include universities, research institutions, and tribal and community organizations, and foreign organizations are listed among eligible applicants. The award maximum is about $500,000, and the model assumes an academic-industry collaboration. It is aimed at research teams.

National Institutes of Health · Amount varies

This NIH/NHLBI R34 funds pilot studies that inform the planning of larger Phase II-IV clinical trials for heart, lung, blood, and sleep disorders; a clinical trial is optional. Eligible applicants include universities, research institutions, and tribal and community organizations; foreign organizations are not eligible to apply, though non-U.S. components of U.S. organizations are. It is a planning mechanism for research teams preparing larger trials. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R01 funds research into population-level approaches for reducing alcohol-related cancer risk, including policy analysis, social-norms research, and intervention testing. It's open to a wide range of research-capable organizations — universities, minority- and tribal-serving institutions, faith-based and community organizations, and federal agencies — though foreign entities face restrictions. No award amount is specified; this is a research grant, not general operating support.

National Institutes of Health · Amount varies

This NIH Gabriella Miller Kids First X01 supports submitting pediatric cohort samples for whole genome and related sequencing to study the genetic basis of childhood cancers and congenital anomalies; no clinical trial is allowed. Foreign (non-U.S.) organizations and foreign components are not eligible. This award provides sequencing at supported genomic centers rather than a cash research budget, so applicants should review the notice; no specific award amount is stated. It is aimed at research teams with existing pediatric cohorts.

National Institutes of Health · Up to $350K

This NIH HEAL Initiative R61/R33 funds early translational drug-discovery research toward non-addictive pain therapeutics, including assay development, screening, and initial characterization of candidate agents; no clinical trial is allowed. Eligible applicants include universities, research institutions, and tribal and community organizations, but foreign organizations are not eligible to apply. The maximum award is about $350,000. It requires drug-discovery research capacity.

National Institutes of Health · Amount varies

An NIH/NIGMS T32 award funding domestic institutions to run Medical Scientist Training Programs that train dual-degree (MD/PhD or equivalent) physician-scientists. Eligible applicants include domestic research institutions, minority-serving and Tribal colleges; foreign institutions and foreign components are not eligible. No award amount is specified. This is an institutional training grant for established medical/research institutions, not for general nonprofits, small businesses, or individuals.

National Institutes of Health · Amount varies

An NIH R24 supporting National Centers for Cryo-electron Tomography that provide shared access to advanced cryoET instrumentation and training. It targets established research institutions able to run a national core facility; foreign organizations and foreign components are not eligible. No award amount is specified, and clinical trials are not allowed. This is a narrow research-infrastructure award, not suited to typical nonprofits, small businesses, or individuals.

National Institutes of Health · Up to $1M

An NIH/NIDDK P30 center grant funding shared research cores and a pilot/feasibility program for diabetes and related metabolic disease research. It is aimed at institutions with an established diabetes research base; only one application per institution is allowed, and foreign organizations are not eligible. Awards reach up to about $1,000,000. This is a center-scale research award for established institutions, not for general nonprofits, small businesses, or individuals.

National Institutes of Health · Up to $500K

An NIH UC2 program helping resource-limited organizations build biomedical research capacity and sponsored-programs administration. Eligible applicants include minority-serving and Tribal colleges and other domestic organizations with limited research resources; foreign organizations are not eligible. Awards reach up to about $500,000. This targets emerging or under-resourced research institutions rather than general nonprofits, small businesses, or individuals.

National Institutes of Health · Amount varies

This NIH cooperative agreement funds translational development of therapeutic and diagnostic devices for nervous-system and neuromuscular disorders, covering clinical prototyping, safety testing, and small clinical studies. It's aimed at research institutions with device-development capacity, including universities and minority-serving institutions, and involves close NIH staff involvement in project planning. No award amount is specified.

National Institutes of Health · Up to $750K

An NIH BRAIN Initiative R18 funding preclinical proof-of-concept work on novel recording and modulation technologies for the human central nervous system, up to readiness for first-in-human studies. The eligibility text is mixed but states foreign organizations and foreign components are not eligible to apply, while domestic research institutions, minority-serving and Tribal colleges may. Awards reach up to about $750,000, and clinical trials are not allowed. This is a specialized research award, not a fit for general nonprofits, small businesses, or individuals.

National Institutes of Health · Amount varies

An NIH BRAIN Initiative R01 funding the development and validation of novel tools to study cell-type- and circuit-specific processes in the brain. Eligibility is geared toward research institutions, including HBCUs, Hispanic-serving and Tribal colleges, and foreign organizations; this is a federal research grant, not a fit for typical nonprofits, small businesses, or individuals without an academic/research affiliation. No award amount is specified. Clinical trials are not allowed under this opportunity.

National Institutes of Health · Up to $750K

An NIH P30 center grant funding shared research cores for digestive and liver diseases research. Only institutions with a strong existing research base, including at least $3 million per year in relevant direct-cost funding (with at least 30% from NIDDK), are eligible, so this effectively requires being an established, heavily NIH-funded institution. Foreign organizations are not eligible. Awards reach up to about $750,000. This is a narrow opportunity for major research centers, not for typical nonprofits, small businesses, or individuals.

National Institutes of Health · Amount varies

An NIDA U01 cooperative agreement funding animal-genomics research into variants linked to addiction and substance use disorders. Eligible applicants include research institutions, minority-serving and Tribal colleges, and foreign organizations. No award amount is specified, and clinical trials are not allowed. This is a federal research grant aimed at investigators, not general nonprofits, small businesses, or individuals.